Abstract:Objective To study the effect of acetylcysteine effervescent tablets on the expression of humoral factors in patients with radiation pneumonia. Methods From Mary 2016 to July 2017, 80 patients with radiation pneumonia in our hospital were selected, and divided into observation group and control group by simple randomized, 40 patients in each group. Patients in control group were treated by pure radiation therapy, and patients in observation group were treated by acetylcysteine effervescent tablets on the base of radiation therapy. The efficacy rate, application of inflammatory factors (CRP, TNF-alpha, IL-6, IL-8 and IL-10) before and after drug, TGF-beta, lung surface active substance (SP-A, SP-D) and expression of GSH were observed. Results After treatment, the effecacy rate of treatment in the observation group (85.00%) was significantly higher than that in the control group (65.00%) (P?0.05). The levels of CRP, TNF-α, IL-6, IL-8 and IL-10 in the observation group were significantly lower than those in the control group (P?0.05). SP-A, SP-D and GSH levels were significantly higher in the observation group than those in the control group (P?0.05). Conclusion Acetylcysteine effervescent tablets may improve the clinical total effecacy rate in treating lung cancer, reduce inflammatory factor expression, and improve the alveolar surface active substance and glutathione expression level, which is worthy of clinical promotion.